NCT05183490

R-MVST Cells for Treatment of Viral Infections

RecruitingPHASE1INTERVENTIONAL

Trial Details

Start: 2022-05-03Est. Completion: 2028-06

Enrollment target: 36 participants

Locations

Contact

Sickling Disorder Due to Hemoglobin S

The purpose of this study is to find the smallest amount of the 131 I-apamistamab needed for preparing patients with sev…

New York, United StatesEst. completion Mar 12, 2030

Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia (r/r B-ALL)

Establishing real-world data of Chinese patients with CD19-positive relapsed/refractory B-cell acute lymphoblastic leuke…

Multiple LocationsEst. completion Dec 2032

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.